A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells

By Sharma Anita   Walters James   Gozes Yehoshua   Fridkin Mati   Brennman Douglas   Gozes Illana   Moody Terry  

Journal of Molecular Neuroscience, Vol. 17, Iss. 3, 2001-12 ,pp. : 331-339

Humana Press, Inc

Access to resources Recommend Favorite

From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: A view of neuroprotection and cell division

By Gozes Illana   Divinsky Inna   Pilzer Inbar   Fridkin Mati   Brenneman Douglas   Spier Avron  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 315-322

Humana Press, Inc

Access to resources Recommend Favorite

Vasoactive Intestinal Peptide (VIP) Regulates Activity-Dependent Neuroprotective Protein (ADNP) Expression In Vivo

By  

Journal of Molecular Neuroscience, Vol. 33, Iss. 3, 2007-11 ,pp. : 278-283

Humana Press, Inc

Access to resources Recommend Favorite

Immunohistochemical study of vasoactive intestinal peptide (VIP) enteric neurons in diabetic rats supplemented with L-glutamine

By Alves Eder Paulo Belato   Alves Angela Maria Pereira   Pereira Renata Virginia Fernandes   Neto Marcílio Hubner de Miranda   Zanoni Jacqueline Nelisis  

Nutritional Neuroscience, Vol. 13, Iss. 1, 2010-02 ,pp. : 43-51

Maney Publishing

Access to resources Recommend Favorite

Differential Regulation of Vasoactive Intestinal Peptide (VIP) in the Dentate Gyrus and Hippocampus via the NO-cGMP Pathway Following Kainic Acid-Induced Seizure in the Rat

By Cosgrave Anna   McKay Jennifer   Thippeswamy Thimmasettappa  

Journal of Molecular Neuroscience, Vol. 42, Iss. 3, 2010-11 ,pp. : 359-369

Humana Press, Inc

Access to resources Recommend Favorite